Bleomycin 30 [USP'U]/1 (Bleomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 30 [USP'U]/1

Bleomycin 30 USP'U/1 is a lyophilized powder injection used for various medical purposes. This medication is manufactured by Hikma Pharmaceuticals USA Inc. and is available in a 1 vial pack size.

Strength

30 [USP'U]/1

Pack Size

1 VIAL in 1 BOX, UNIT-DOSE (0143-9241-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIA

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bleomycin 30 USP'U/1 is commonly used for certain types of cancer treatments. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. The specific uses of Bleomycin can vary, and it is often administered based on individual patient needs and medical protocols.

Side Effects

When administered, Bleomycin 30 USP'U/1 may cause various effects, including fatigue, nausea, and skin reactions. Some patients might experience more severe side effects, which should be discussed with a healthcare provider. The exact effects can vary depending on the individual and the specific treatment plan.

Precautions & Warnings

Bleomycin 30 USP'U/1 should be handled with care and stored as directed. It is important to follow the administration guidelines provided by a healthcare professional to ensure safety. Patients should be monitored for any adverse reactions and report them promptly.

Avoid Interactions

Bleomycin 30 USP'U/1 may interact with other medications, including certain antibiotics and chemotherapy drugs. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of Bleomycin.

Frequently Asked Questions

Bleomycin 30 USP'U/1 is primarily used in the treatment of certain types of cancer. It is often part of a chemotherapy regimen.

Bleomycin 30 USP'U/1 can be administered intramuscularly, intraperitoneally, intravenously, or subcutaneously, depending on the treatment plan.

Common side effects may include fatigue, nausea, and skin reactions. Severe side effects should be reported to a healthcare provider.

Bleomycin 30 USP'U/1 may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Bleomycin 30 USP'U/1 should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.